Pages that link to "Q33588113"
Jump to navigation
Jump to search
The following pages link to Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers (Q33588113):
Displaying 23 items.
- Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma (Q30600084) (← links)
- A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. (Q33968948) (← links)
- Development of a multiplex autoantibody test for detection of lung cancer (Q35154906) (← links)
- Autoantibody signatures: progress and perspectives for early cancer detection (Q35377236) (← links)
- Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts (Q37549330) (← links)
- Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. (Q37635618) (← links)
- Current readings: blood-based biomarkers for lung cancer. (Q37672473) (← links)
- Survivin signaling in clinical oncology: a multifaceted dragon (Q38017923) (← links)
- Molecular biomarkers for future screening of lung cancer (Q38124776) (← links)
- Current status of circulating protein biomarkers to aid the early detection of lung cancer. (Q38232856) (← links)
- Asthma-Predictive Genetic Markers in Gene Expression Profiling of Peripheral Blood Mononuclear Cells (Q38547629) (← links)
- Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer (Q40150329) (← links)
- IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. (Q40478066) (← links)
- Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. (Q41294153) (← links)
- Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets. (Q44646012) (← links)
- IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. (Q46256483) (← links)
- IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling (Q46873887) (← links)
- Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity (Q47187009) (← links)
- Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD. (Q51540951) (← links)
- The grand challenge to decipher the cancer proteome (Q51901383) (← links)
- The state of the art in the development of a panel of biomarkers for the early detection of lung cancer. (Q55016891) (← links)
- Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma (Q89698200) (← links)
- Blood based biomarkers beyond genomics for lung cancer screening (Q90541051) (← links)